Background Neonatal abstinence syndrome (NAS) due to opioid withdrawal may result in
disruption of the mother‐infant relationship, sleep‐wake abnormalities, feeding difficulties …

Background Neonatal abstinence syndrome (NAS) due to opioid withdrawal may result in
disruption of the mother–infant relationship, sleep–wake abnormalities, feeding difficulties …

Background The prevalence of substance use, both prescribed and non‐prescribed, is
increasing in many areas of the world. Substance use by women of childbearing age …

Background Neonatal abstinence syndrome (NAS) due to opiate withdrawal may result in
disruption of the mother‐infant relationship, sleep‐wake abnormalities, feeding difficulties …

Background Neonatal abstinence syndrome (NAS) due to opiate withdrawal may result in
disruption of the mother‐infant relationship, sleep‐wake abnormalities, feeding difficulties …

Background: The evaluation and management of infants with neonatal abstinence syndrome
(NAS), the constellation of opioid withdrawal specific to newborns, have received renewed …

Introduction Rates of neonatal opioid withdrawal syndrome (NOWS) have paralleled the rise
of opioid use during pregnancy. While short-term phenotypic symptoms of NOWS are well …

Objective (s) To compare short-term treatment outcomes of opioid pharmacotherapy for
neonatal opioid withdrawal syndrome (NOWS). Study design PubMed/MEDLINE, Embase …

This study assessed the economic evidence on the pharmacological and non-
pharmacological management of infants with neonatal opioid withdrawal syndrome …

BACKGROUND: As rates of neonatal opioid withdrawal are increasing, the need for
research to evaluate new treatments is growing. Large heterogeneity exists in health …